Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Opinion & Analysis Innovation1 Biotech Inc. IVBT

Innovation1 Biotech Inc is a pharmaceutical, small molecule, research and development company focused on the discovery and clinical development of novel therapeutics for major unmet medical needs. The company's portfolio includes five proprietary, fully synthetic preclinical prodrugs addressing independent clinical indications: a mushroom-derived psychedelic molecule for treatment of post-traumatic stress disorder and depression, a novel cannabinoid for treatment of addiction and three additional cannabinoid prodrugs addressing clinical indications of refractory epilepsy, burn wounds and uveitis.


Opinion & Analysis (OTCQB:IVBT)

    No current opinion is available.